CANOPY-A: A phase III, placebo-controlled study of canakinumab as adjuvant therapy in patients (pts) with surgically resected NSCLC

被引：0

作者：

Cho, B. C. ^{[1
]}

Chang, G-C. ^{[2
]}

Kim, Y-C. ^{[3
]}

Geater, S. ^{[4
]}

Saeteng, S. ^{[5
]}

Yang, C-T. ^{[6
]}

Goto, Y. ^{[7
]}

Lu, S. ^{[8
]}

Ardizzoni, A. ^{[9
]}

Barlesi, F. ^{[10
]}

De Marchi, P. ^{[11
]}

Paz-Ares, L. ^{[12
]}

Spigel, D. R. ^{[13
]}

Thomas, M. ^{[14
]}

Garon, E. B. ^{[15
]}

Leung, M. ^{[16
]}

Baum, J. ^{[17
]}

Zewen, Z. ^{[18
]}

Mookerjee, B. ^{[16
]}

Yang, J. C-H. ^{[19
]}

机构：

[1] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea

[2] Taichung Vet Gen Hosp, Dept Internal Med, Div Chest Med, Taichung, Taiwan

[3] ChonnamNatl Univ, Lung Canc Clin, Dept Internal Med, Hwasun Hosp, Jeollanam Do, South Korea

[4] Songklanagarind Hosp, Fac Med, Dept Internal Med, Songkhla, Thailand

[5] Chiang Mai Univ, Fac Med, Dept Surg, Chiang Mai, Thailand

[6] Chang Gung Mem Hosp, Dept Thorac Med, Taoyuan, Taiwan

[7] Natl Canc Ctr, Dept Thorac Oncol, Tokyo, Japan

[8] Shanghai Chest Hosp, Dept Med Oncol, Shanghai, Peoples R China

[9] St Orsola Malpighi Univ Polyclin, Dept Oncol & Hematol, Bologna, Italy

[10] Aix Marseille Univ, Dept Med Oncol, Marseille, France

[11] Hosp Canc Barretos, Dept Med Oncol, Sao Paulo, SP, Brazil

[12] Univ Hosp 12 Octubre, Dept Med Oncol, Madrid, Spain

[13] Sarah Cannon Res Inst, Dept Med Oncol, Nashville, TN USA

[14] Thoraxklin Univ Klinikum Heidelberg, Internist Onkol Thoraxtumoren, Dept Thorac Oncol Internal Med, German Ctr Lung Res DZL,TLRC H, Heidelberg, Germany

[15] UCLA TRIO US Network, David Geffen Sch Med, Dept Hematol Oncol, Los Angeles, CA USA

[16] Novartis Pharmaceut, Dept Oncol, E Hanover, NJ USA

[17] Novartis Inst BioMed Res, Dept Oncol, Cambridge, MA USA

[18] Novartis Pharmaceut, Dept Biostat, E Hanover, NJ USA

[19] Natl Taiwan Univ Hosp, Dept Med Oncol, Taipei, Taiwan

来源：

ANNALS OF ONCOLOGY | 2019年 / 30卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

531TiP

引用

页数：2

共 50 条

[41] BRIM8: a randomized, double-blind, placebo-controlled study of adjuvant vemurafenib in patients (pts) with completely resected, BRAFV600+melanoma at high risk for recurrence
Lewis, K.
Maio, M.
Demidov, L.
Mandala, M.
Ascierto, P. A.
Herbert, C.
Mackiewicz, A.
Rutkowski, P.
Guminski, A.
Goodman, G.
Simmons, B.
Ye, C.
Yan, Y.
Schadendorf, D.
ANNALS OF ONCOLOGY, 2017, 28
[42] MERMAID-1: A Phase III Study on adjuvant Therapy with Durvalumab plus Chemotherapy in resected and postoperative MRD-positive (MRD +) NSCLC-Patients
Reinmuth, N.
Peters, S.
PNEUMOLOGIE, 2021, 75 : S11 - S12
[43] Celecoxib in docetaxel/carboplatin treated patients (pts) with advanced non-small cell lung cancer (NSCLC): interaction of treatment with histology; a randomized placebo-controlled phase III study of the NVALT Group
Groen, Harry J.
van Putten, John W.
Hochstenbag, Monique M.
Vincent, Andrew
Dalesio, Otilia
Smit, Hans J.
Termeer, Rene
van den Borne, Ben E.
Biesma, Bonne
Schramel, Franz M.
JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S382 - S382
[44] CARNOSINE AS AN ADJUVANT THERAPY IN PEDIATRIC PATIENTS WITH DIABETIC NEPHROPATHY: A RANDOMIZED PLACEBO-CONTROLLED TRIAL
Elbarbary, Nancy S.
Ismail, Eman Abdel Rahman
El-Naggar, Abdel Rahman
Hamouda, Mahitab Hany
El-Hamamsy, Manal
HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 22 - 22
[45] Phase III randomized controlled trial of adjuvant chemoimmunotherapy in patients with resected primary lung cancer
Kimura, H.
Matsui, Y.
Nakajima, T.
Iizasa, T.
Ishikawa, A.
ANNALS OF ONCOLOGY, 2017, 28
[46] Canakinumab or pembrolizumab as monotherapy or in combination as neoadjuvant therapy in patients with surgically resected non-small cell lung cancer: CANOPY-N trial.
Lee, Jay M.
Mok, Tony
Garrido, Pilar
Kim, Edward S.
Arslan, Cagatay
Tsuboi, Masahiro
Dong, Tuochuan
Blin, Cecile
Rodrik-Outmezguine, Vanessa
Mookerjee, Bijoyesh
Passos, Vanessa
Pujol, Jean-Louis
CANCER RESEARCH, 2021, 81 (13)
[47] PICASSO III: A Phase III, Placebo-Controlled Study of Doxorubicin With or Without Palifosfamide in Patients With Metastatic Soft Tissue Sarcoma
Ryan, Christopher W.
Merimsky, Ofer
Agulnik, Mark
Blay, Jean-Yves
Schuetze, Scott M.
Van Tine, Brian A.
Jones, Robin L.
Elias, Anthony D.
Choy, Edwin
Alcindor, Thierry
Keedy, Vicki L.
Reed, Damon R.
Taub, Robert N.
Italiano, Antoine
Garcia del Muro, Xavier
Judson, Ian R.
Buck, Jill Y.
Lebel, Francois
Lewis, Jonathan J.
Maki, Robert G.
Schoffski, Patrick
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (32) : 3898 - +
[48] Phase III multicenter placebo-controlled study of tamsulosin in benign prostatic hyperplasia
Lepor, H
UROLOGY, 1998, 51 (06) : 892 - 900
[49] A Randomised, Placebo-Controlled, Phase II Trial of Adjuvant Avelumab in Patients with Stage I-III Merkel Cell Carcinoma
Xu, Wen
Poulsen, Michael
Atkinson, Victoria
Fogarty, Gerald
Veness, Michael
Smithers, Bernard
Gyorki, David
Mar, Victoria
Guminski, Alexander
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 : 20 - 20
[50] Randomized, placebo-controlled, phase III surgical adjuvant clinical trial of megestrol acetate (Megace) in selected patients with malignant melanoma
Markovic, S
Suman, VJ
Dalton, RJ
Woods, JE
Fitzgibbons, RJ
Wold, LE
Buckner, JC
Kugler, JW
Mailliard, JA
Rowland, KM
Krook, JE
Brown, DW
Tirona, MT
Creagan, ET
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (06): : 552 - 556

← 1 2 3 4 5 →